Product NDC: | 0009-0280 |
Proprietary Name: | Depo-Medrol |
Non Proprietary Name: | methylprednisolone acetate |
Active Ingredient(s): | 40 mg/mL & nbsp; methylprednisolone acetate |
Administration Route(s): | INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-0280 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011757 |
Marketing Category: | NDA |
Start Marketing Date: | 19590528 |
Package NDC: | 0009-0280-03 |
Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (0009-0280-03) |
NDC Code | 0009-0280-03 |
Proprietary Name | Depo-Medrol |
Package Description | 10 mL in 1 VIAL, MULTI-DOSE (0009-0280-03) |
Product NDC | 0009-0280 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | methylprednisolone acetate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRALESIONAL; INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE |
Start Marketing Date | 19590528 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | METHYLPREDNISOLONE ACETATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |